![]() |
市場調査レポート
商品コード
1668344
カテーテル市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、最終用途別、地域別、競合別、2020~2030年Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End Use, By Region and Competition, 2020-2030F |
||||||
カスタマイズ可能
|
カテーテル市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、最終用途別、地域別、競合別、2020~2030年 |
出版日: 2025年02月28日
発行: TechSci Research
ページ情報: 英文 187 Pages
納期: 2~3営業日
|
カテーテルの世界市場規模は2024年に584億5,000万米ドルとなり、2030年には802億7,000万米ドルに達すると予測され、予測期間中のCAGRは5.39%で推移すると予測されています。
同市場は、慢性疾患の増加、世界人口の高齢化、医療技術の進歩などを背景に、近年大きな成長を遂げています。カテーテルは、心臓血管、泌尿器、神経血管、静脈内処置など、さまざまな用途に使用される重要な医療機器です。病院、外来手術センター、在宅ヘルスケアなどで広く使用されていることが、この拡大に寄与しています。さらに、低侵襲処置に対する意識の高まりが、革新的なカテーテル技術への需要を加速させています。
市場概要 | |
---|---|
予測期間 | 2026~2030年 |
市場規模:2024年 | 584億5,000万米ドル |
市場規模:2030年 | 802億7,000万米ドル |
CAGR:2025~2030年 | 5.39% |
急成長セグメント | 循環器カテーテル |
最大市場 | 北米 |
カテーテル市場の成長を牽引する主な要因は、心血管疾患(CVD)と泌尿器疾患の罹患率の上昇です。血管造影カテーテルや電気生理カテーテルなどの心血管カテーテルは、心臓疾患の診断や治療に広く使用されています。同様に、尿道カテーテルは尿失禁やその他の膀胱関連の問題を抱える患者、特に高齢者に不可欠です。慢性疾患の有病率の増加と外科手術件数の増加は、カテーテルの需要を維持すると予想されます。
カテーテル設計と材料における技術的進歩が市場拡大の鍵を握っています。抗菌剤コーティングカテーテルや薬剤溶出カテーテルの開発により、カテーテル治療に伴う感染リスクが大幅に低下しました。さらに、リアルタイムモニタリング用のセンサーを搭載したスマートカテーテルの登場により、患者の安全性と治療成績が向上しました。メーカー各社はまた、カテーテルの耐久性と性能を向上させ、患者に優しいカテーテルを実現するために、生体適合性材料にも注力しています。
慢性疾患の有病率の上昇
入院と外科手術の増加
価格圧力と償還問題
サプライチェーンの混乱と材料不足
技術の進歩
The global catheter market was valued at USD 58.45 billion in 2024 and is projected to reach USD 80.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.39% during the forecast period. The market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases, an aging global population, and advancements in medical technology. Catheters are vital medical devices used in a variety of applications, including cardiovascular, urology, neurovascular, and intravenous procedures. Their widespread use across hospitals, ambulatory surgical centers, and home healthcare settings has contributed to this expansion. Furthermore, rising awareness of minimally invasive procedures has accelerated demand for innovative catheter technologies.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 58.45 Billion |
Market Size 2030 | USD 80.27 Billion |
CAGR 2025-2030 | 5.39% |
Fastest Growing Segment | Cardiovascular Catheter |
Largest Market | North America |
A major factor driving growth in the catheter market is the rising incidence of cardiovascular diseases (CVDs) and urinary disorders. Cardiovascular catheters, such as angiography and electrophysiology catheters, are widely used in the diagnosis and treatment of heart conditions. Similarly, urinary catheters are essential for patients with urinary incontinence and other bladder-related issues, particularly in the elderly. The increasing prevalence of chronic diseases, coupled with the rising number of surgical procedures, is expected to sustain the demand for catheters.
Technological advancements in catheter design and materials have been key in expanding the market. The development of antimicrobial-coated and drug-eluting catheters has significantly reduced infection risks associated with catheterization. Additionally, the emergence of smart catheters, equipped with sensors for real-time monitoring, has improved patient safety and treatment outcomes. Manufacturers are also focusing on biocompatible materials to enhance the durability and performance of catheters, making them more patient-friendly.
Key Market Drivers
Rising Prevalence of Chronic Diseases
The global catheter market is experiencing strong growth, largely driven by the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, urinary incontinence, and neurological conditions. These diseases often require continuous treatment, surgical procedures, and hospital care, with catheters playing a crucial role in patient management. Additionally, the growing geriatric population, technological advancements in catheter design, and the expansion of healthcare infrastructure worldwide have further increased demand for these devices.
Cardiovascular diseases (CVDs) are a leading cause of death globally, with conditions such as coronary artery disease, heart failure, and arrhythmias requiring catheter-based interventions. According to the World Health Organization (WHO), CVDs cause approximately 17.9 million deaths annually, underscoring the need for advanced cardiac treatments. Catheters are crucial in procedures such as angioplasty, electrophysiology studies, and cardiac catheterization. As minimally invasive techniques gain popularity, the demand for advanced cardiovascular catheters, including balloon catheters, electrophysiology catheters, and guiding catheters, has increased. The growing number of catheter-based cardiac ablation procedures to treat atrial fibrillation further boosts market demand. Moreover, innovations like steerable catheters and bioresorbable stents have enhanced the efficacy of catheter-based cardiac interventions.
Diabetes is another significant driver of catheter demand, as the condition is associated with various complications, such as kidney disease, neuropathy, and urinary retention, which often require catheter interventions. The International Diabetes Federation (IDF) estimates that over 537 million adults were living with diabetes in 2021, with the number expected to reach 783 million by 2045. For diabetic patients with end-stage renal disease (ESRD), hemodialysis is a critical treatment, requiring the use of tunneled and non-tunneled dialysis catheters. Furthermore, insulin pump therapy, which uses catheter-based infusion sets, is becoming more popular for better glycemic control, contributing to market growth.
Urinary incontinence and other bladder disorders are increasingly common, particularly among the aging population. Conditions such as benign prostatic hyperplasia (BPH), neurogenic bladder, and spinal cord injuries often necessitate catheterization for urine drainage. Foley catheters, intermittent catheters, and external catheters are commonly used for managing urinary retention and incontinence. The aging population is a major factor driving the growing demand for urinary catheters. According to the United Nations, the number of individuals aged 65 and older is expected to double by 2050, reaching 1.5 billion. As age-related urological disorders become more prevalent, the need for long-term catheter use in home healthcare settings is increasing. Additionally, the rising acceptance of self-catheterization for greater patient independence is accelerating market growth.
Increasing Hospitalizations and Surgical Procedures
The global catheter market is also expanding due to the rising number of hospitalizations and surgical procedures. Catheters are essential medical devices used in numerous diagnostic and therapeutic applications, making them indispensable in modern healthcare. The growing prevalence of chronic diseases, combined with advancements in medical technology, has significantly increased catheter demand. As healthcare providers aim to improve patient outcomes and minimize complications, the catheter market is set for continued growth.
The World Health Organization (WHO) reports that millions of people undergo surgical procedures annually, with surgery contributing to approximately 13% of global disability-adjusted life years (DALYs). An important driver of market growth is the increasing number of surgical interventions across various medical specialties. CVDs, a leading cause of global mortality, often require frequent catheter-based medical interventions. Procedures such as angioplasty, stent placement, and electrophysiology studies rely heavily on the use of cardiovascular catheters. The increasing incidence of heart diseases, driven by factors like aging populations, sedentary lifestyles, and poor dietary habits, has led to a higher number of cardiac surgeries and catheter-based treatments.
Key Market Challenges
Pricing Pressure and Reimbursement Issues
The catheter market is highly competitive, resulting in significant pricing pressures among manufacturers. Healthcare providers and governments, especially in cost-sensitive regions, are demanding lower prices for medical devices, which erodes profit margins for companies. Furthermore, reimbursement policies vary across countries, impacting the affordability of catheters for patients. In some regions, limited insurance coverage or restrictive reimbursement policies may reduce accessibility to advanced catheter technologies, hindering market growth.
Supply Chain Disruptions and Material Shortages
The global supply chain for medical devices, including catheters, has been significantly disrupted by geopolitical tensions, trade restrictions, and logistical bottlenecks. The COVID-19 pandemic exposed vulnerabilities in supply chains, leading to shortages of essential raw materials such as silicone, latex, and polyurethane, which are critical in catheter manufacturing. These disruptions have resulted in increased production costs and delays in product availability, affecting both manufacturers and healthcare providers.
Key Market Trends
Technological Advancements
The catheter market is experiencing substantial growth driven by rapid technological innovations. Advances in catheter materials, design, and functionality are enhancing patient comfort, reducing infection risks, and improving overall procedural efficiency. Key innovations include the development of antimicrobial coatings, hydrophilic surface modifications, and the use of biocompatible materials like silicone and polyurethane, which have improved flexibility, durability, and compatibility with the human body. These advancements make catheters more effective and patient-friendly, further driving market expansion.
Report Scope
This report provides a detailed analysis of the global catheter market, segmented into the following categories: